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ABSTRACT 
 
The obesity epidemic is on the rise, and currently represents the largest global health threat. 
Westernization and advances in food production have led to a contemporary diet comprised 
of 49 % energy from carbohydrates, 35 % from fats and 16 % from proteins. Former studies 
have demonstrated the weight-reducing benefits of increasing the amount of dietary protein 
at the expense of sucrose in high-fat diets, but the impact of specific proteins has not been 
elucidated. An unpublished study from our group discovered that different protein sources 
exert dissimilar obesogenic effects in mice when included in a high-protein diet. While 
proteins from pork promoted obesity development and proteins from cod had an 
intermediate effect, casein was the only protein to protect against diet-induces obesity. 
Moreover, the study registered a higher energy intake in the mice fed pork compared to the 
mice fed cod.  
We undertook our current study to investigate the obesogenic effect of different proteins 
and the satiating effect of cod proteins in a high-fat high-protein diet. Additionally, we aimed 
to expound on the various mechanisms by which different proteins affect obesity 
development. Thus, obesity-prone C57BL/6J mice were fed high-fat high-protein diets with 
casein, cod or pork as the protein source, with one pork group being pair fed with the group 
fed cod. Furthermore, we found it interesting to explore the weight-reducing effects of the 
same protein sources on diet induced obese mice. Hence, obese C57BL/6J mice were fed 
low-fat diets with casein, cod or pork as the protein source. In agreement with earlier 
studies, our results demonstrated that casein was the only protein to attenuate the 
obesogenic effect of a high-fat diet. On the contrary, mice fed pork gained a significant 
amount of fat mass and had an impaired glucose tolerance. Furthermore, our results 
demonstrated that cod-protein had an intermediate effect. In contrast to previous 
observations, the cod proteins did not promote satiety in a higher degree than proteins from 
pork. In our second animal experiment, we observed a significantly higher weight loss and an 
improved glucose tolerance in obese mice fed a low fat diet with casein. Collectively, our 
results underscore that the dietary protein source is an important factor to abrogate the 
development of obesity, and implies that it might be beneficial to increase the amount of 
dietary casein at the expense of pork proteins. 
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1. INTRODUCTION 
 
 
1.1 OVERWEIGHT AND OBESITY 
Overweight and obesity is defined as an excessive or abnormal accumulation of fat that may 
lead to multiple co-morbidities (WHO).  
 
1.1.1 Quantification of overweight and obesity 
 
Body mass index (BMI) is a widely used method for diagnosing and classifying overweight 
and obesity, which provides a number that indicate general body fatness (WHO 2012). To 
calculate BMI, the body weight in kilograms is divided by the square of height in meters 
(kg/m2). WHO provides a classification of BMI, where a BMI of 25 kg/m2 or higher is 
considered overweight, and a BMI of 30 kg/m2 or above is classified as obese. Although BMI 
is a good indicator of a person’s general health status, it does not consider factors such as 
bone density, muscle-and fat mass ratio or body shape. Waist-to-hip ratio can be measured 
to obtain information regarding fat deposition, and it accounts for differences in body shape 
(Karelis, St-Pierre et al. 2004). Having a pear shaped body, which is most common with 
women, is considered to lower the risk of developing obesity-related diseases due to 
subcutaneous fat deposition. Individuals with an apple shaped body are at a higher risk of 
developing cardiovascular diseases and diabetes type 2, as they have increased visceral fat 
deposition (Haslam and James 2005). A more precise measurement of fat depots may be 
obtained by dual-energy X-ray absorptiometry (DEXA) or magnetic resonance imaging (MRI) 
(James 2004). Nevertheless, these methods are expensive to perform and are not of general 
clinical relevance.  
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1.1.2 Prevalence of overweight and obesity 
 
The prevalence of overweight and obesity has doubled since the 1980s, with an estimated 
1.4 billion adults being overweight and 500 million adults being obese in 2008 (WHO 2012). 
Islands in the South Pacific have the highest rate of adult obesity worldwide (>50%), 
followed by large countries such as Mexico (32.8%) and the USA (31.8%) (FAO 2013). In 
Norway the average body weight has increased by 6 kg since 1985 and today more than half 
of the adult population is overweight and 15-20 % is obese (Folkehelseinstituttet 2012). 
Childhood overweight is also on the rise, particularly in developing countries (WHO 2012).  
More than 30 million overweight children under the age of five live in developing countries 
while 10 million live in developed countries. Hence, to define overweight and obesity as a 
high-income country problem is no longer viable, as the prevalence is rising more rapidly in 
middle-and low-income countries. Underweight has been a global challenge for decades, 
however, 65% of the world’s population currently live in countries where obesity and 
overweight causes more deaths than underweight. 
 
1.1.3 Causative factors of overweight and obesity 
 
The primary cause of the increasing prevalence of overweight and obesity is an energy 
imbalance between calories consumed and calories expended. One of the contributing 
factors to reduced energy expenditure is the modern sedentary lifestyle. Additionally, there 
has been dramatic changes in food production and consumption in the past centuries (FAO 
2013). Food production has evolved from self-sufficient farming, to industrial production of 
more energy-dense foods containing higher amounts of sugar, omega-6 fatty acids and salt. 
In addition to energy imbalance, genetic factors can affect the prevalence of obesity on 
many levels such as appetite control, energy metabolism and hereditary traits 
(Pelleymounter, Cullen et al. 1995). A relation between social class and risk of developing 
obesity has also been established, along with migration and other behavioural factors (Ball, 
Mishra et al. 2003; Rankinen, Zuberi et al. 2006). The causes of overweight and obesity are 
intricate, and as varied as the people it affects.  
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1.1.4 The pathophysiology of overweight and obesity 
 
Excess body weight is considered to be the fifth leading risk factor of global deaths and is 
attributable to a series of associated disorders (Guh, Zhang et al. 2009). Overweight and 
obesity are associated with development of insulin resistance and type 2 diabetes along with 
cardiovascular diseases as atherosclerosis and stroke.  Additionally, obesity promotes 
secretion of inflammatory cell signalling proteins which increase the risk of developing 
various types of cancer, including colon and oesophageal cancer (Redinger 2007). Obesity 
may also lead to female reproductive problems and infertility, due to increased secretion of 
fertility-associated hormones (Brothers, Wu et al. 2010). Furthermore, sleep apnea and 
osteoarthritis due to excess weight are common in obese individuals. This cluster of co-
morbidities is currently the largest global health threat.  
 
1.2 THE ADIPOSE ORGAN 
The adipose organ consists of intermingled white and brown adipocytes. While white 
adipocytes are mainly used as a lipid storage that functions as fuel between meals, the 
brown adipocytes burn fat to produce heat.    
 
1.2.1 White adipose tissue (WAT) 
 
White adipose tissue (WAT) consists of unilocular white adipocytes containing a single large 
lipid droplet surrounded by a thin rim of cytoplasm (Cinti 2009). The lipid droplets are semi-
liquid and primarily comprised of triacylglycerols (TAGs). In addition to function as an energy 
storage, it has been discovered that WAT is an active endocrine organ that secrete protein 
signals and factors (Kershaw and Flier 2004). These signals and factors include leptin, 
adiponectin, tumor necrosis factor α (TNF-α), proteins of the renin-angiotensin system, 
interleukin 6, plasminogen activator inhibitor-1 and resistin. Obesity is known to alter the 
endocrine function of adipose tissue and lead to an increased secretion of pro-inflammatory 
cytokines from macrophages (Weisberg, McCann et al. 2003). The elevated cytokine 
secretion induces chronic inflammation, which is considered as a causative factor for 
developing insulin resistance. (Xu, Barnes et al. 2003). 
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1.2.2 Brown adipose tissue (BAT) 
 
Brown adipose tissue (BAT) is composed of multilocular brown adipocytes that store 
triglycerides in small vacuoles and numerous large mitochondria packed with laminar cristae 
(Cinti 2009). Unlike WAT, BAT uses lipids to produce heat through non-shivering 
thermogenesis. The process is activated by mitochondrial uncoupling protein-1 (UCP1), 
which is found solely in brown adipocytes (Cannon, Hedin et al. 1982; Frontini, Rousset et al. 
2007). UCP1 allows the uncoupling of protons from oxidative phosphorylation and adenosin-
5'-trifosfat (ATP) synthesis, resulting in thermogenesis. The metabolic activity of BAT is 
regulated via release of norepinephrine from the sympathetic nervous system (SNS) which 
binds to G-protein coupled β-adrenergic receptors in BAT (Townsend and Tseng 2012). 
Activation of the receptor triggers production of cyclic-adenosine monophosphate (cAMP) 
and protein kinase A (PKA) activation. Activated PKA leads to phosphorylation and activation 
of hormone sensitive lipase (HSL), which accelerates free fatty acid (FFA) release from stored 
triglycerides. FFAs enters the mitochondria and are used for either β-oxidation or activation 
of UCP1-induced thermogenesis.   
 
Occurrence of brown adipose tissue 
 
Brown adipose tissue is a mammalian prerogative, which provides the ability to regulate 
body temperature through non-shivering thermogenesis. Although BAT was serendipitously 
discovered in the 16th century, its physiological properties were not supported until the 
1960s. Metabolically active BAT has been known to exist in the interscapular region of small 
animals and infants, but the discovery of UCP1 positive brown adipose tissue (hBAT) in 
human adults is a fairly recent discovery. In 2009, metabolically active hBAT in adults was 
detected by using positron emission tomography (PET) and glucose tracers (Cypess, Lehman 
et al. 2009; van Marken Lichtenbelt, Vanhommerig et al. 2009; Virtanen, Lidell et al. 2009). 
This recent discovery rekindled the interest in human adipose biology and its potential 
therapeutic benefits.  
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Transcriptional regulation of brown and “beige” adipocytes 
 
Brown adipocytes are believed to derive from precursor cells that express the Myf5+ gene, 
which also gives rise to white adipocytes and skeletal muscle (Seale, Bjork et al. 2008; 
Sanchez-Gurmaches, Hung et al. 2012). Furthermore, brown precursor cells express a gene 
signature similar to muscles and a related mitochondrial protein expression. In addition to 
activation of brown adipocytes, it has been established that stimuli by cold acclimatization or 
β-adrenergic agonists induce the appearance of a different UCP1-expressing adipocyte in 
WAT; the “beige” or “brite” adipocyte (Cousin, Cinti et al. 1992; Guerra, Koza et al. 1998; 
Wu, Bostrom et al. 2012). While brown adipocytes are found in specific anatomical depots 
and express high levels of UCP1 in an unstimulated state, the “beige” adipocytes appear 
intermingled in WAT and only express UCP1 when stimulated (Petrovic, Walden et al. 2010; 
Wu, Cohen et al. 2013). “Beige” adipocytes derive from transdifferentiation of mature white 
adipocytes, de novo differentiation of precursor cells or a combination of these phenomena. 
Cinti and colleagues have shown that cold-induced browning in WAT is mainly due to 
transdifferentiation of mature white adipocytes (Cinti 2009), while recent in vivo mapping 
studies have unveiled Myf5 negative brown adipocytes in WAT after adrenergic stimulation 
(Timmons, Wennmalm et al. 2007; Seale, Bjork et al. 2008). The findings of Timmons and 
colleagues suggest that “beige” adipocytes may have a dissimilar origin then the classical 
brown adipocyte, but a unanimous conclusion has not yet been presented. A description of 
both transcriptional theories on brown and “beige” adipocyte regulation is presented in 
figure 1.1. 
 
In summary, browning of white adipose tissue may represent a new therapeutic target in the 
prevention of obesity and its co-morbidities. Several animal studies have shown an increased 
amount of “beige” adipocytes in obesity-resistant mice, but human studies are still at its 
inception (Xue, Rim et al. 2007; Vitali, Murano et al. 2012). 
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Figure 1.1: Transcriptional regulation of brown and beige adipocyte development (a) Brown 
adipocytes are derived from a Myf5-expressing progenitor population. Ebf2 cooperates with Ppar-γ to 
promote the expression of Prdm16, which drives a brown-fat cell fate. Thermogenesis in mature 
brown adipocytes is activated by norepinephrine (NE), a β3 agonist, released from sympathetic 
neurons. NE signals through β-adrenoreceptors to increase the expression and activity of Pgc-1α, a 
transcriptional coactivator that coordinates gene programming in response to activation. (b) In 
inguinal fat, β-adrenergic stimulation triggers predominantly de novo differentiation of precursor 
cells (large arrow). We leave open the possibility that under some conditions, mature white fat cells 
can transdifferentiate into beige cells (small dashed arrow). In epididymal WAT, caloric excess causes 
bipotent progenitors to differentiate into white adipocytes, whereas β-adrenergic activators stimulate 
beige adipocyte development. TZD agonists of Ppar-γ promote beiging both by increasing the stability 
of Prdm16 and through the Sirt1-dependent deacetylation of Ppar-γ, which recruits Prdm16 to Ppar-γ 
target genes. β-adrenergic signaling drives the expression and activity of Pgc-1α in beige adipocytes. 
Pgc-1α is targeted by numerous repressors to block beige adipocyte development. Ac, acetylation. 
Figure and figure text are adapted from (Harms and Seale 2013).  
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1.3 WEIGHT REDUCTION AND OBESITY PREVENTION 
 
1.3.1 Macronutrients 
 
The main cause for obesity development is a long-term energy imbalance, although the true 
understanding of its causative factors and treatment options remains uncertain. The 
contemporary Western diet is energy dense and contains a high level of carbohydrates, 
especially starches and processed carbohydrates. By introducing more dietary 
carbohydrates, the intake of protein has been dramatically reduced when compared to 
typical Stone-age and Hunter-gatherer diets (Cordain, Eaton et al. 2005; Eaton 2006). In 
addition to a more sedentary lifestyle, the shift in dietary macronutrient composition may 
contribute to the increasing prevalence of obesity and type 2 diabetes. While the Norwegian 
Health Authorities recommend a diet high in carbohydrates and low in fat to prevent 
obesity, many alternative approaches have emerged (Helsedirektoratet 2014). The definition 
of the perfect dietary macronutrient-balance is widely debated, with each combination 
presenting their pros and cons. New dietary trends emerge continuously, and lately high-
protein diets have gained attention as a popular method to lose weight.  
 
1.3.2 Low-fat diets 
 
Low fat (LF) diets are based on the restriction of dietary fat, specifically saturated -and trans 
fatty acids. Limiting the dietary fat has been a popular way of reducing calorie intake, given 
that fat is the most energy-dense macronutrient (9 kcal/g). Traditionally a LF diet consists of 
10-20 E% from proteins, 45-60 E% from carbohydrates and 25-40 E% from fat 
(Helsedirektoratet 2014). In obese and overweight individuals, calorie restricted LF diets 
have induced substantial weight loss, reduced cholesterol levels and improved glucose 
tolerance (Sacks, Bray et al. 2009) . However, LF diets have been observed to promote 
gluttony in a higher degree than HP diets. The protein-leverage hypothesis proposes that 
protein intake is prioritized over the intake of the other macronutrients, resulting in a higher 
energy-intake in diets low in protein (Sorensen, Mayntz et al. 2008). Furthermore, the 
weight loss ratio between fat-and lean mass produced by low-fat diets has been debated, 
and many advocate for a higher percentage of dietary protein (Leidy, Carnell et al. 2007). 
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1.3.3 High-protein diets 
 
High protein (HP) diets were previously most common amongst bodybuilders and athletes, 
but have lately gained increased interest as a method for weight management. There is no 
specific definition of a HP diet, but an intake of >1.6 g/kg or >25 E% protein can be regarded 
as high (Eisenstein, Roberts et al. 2002). Studies and meta-analyses have demonstrated that 
both calorie-restricted and ad libitum HP diets promote weight loss in the form of fat, 
improve glucose homeostasis and maintains lean mass in human subjects (Skov, Toubro et 
al. 1999; Layman, Boileau et al. 2003; Krieger, Sitren et al. 2006). Similar evidence has been 
presented in studies with rats, where a long-term HP diet reduced white adipose tissue mass 
and lowered basal concentrations of triglycerides, glucose  and insulin (Lacroix, Gaudichon et 
al. 2004). The potential negative effects of a high protein intake on renal function and 
urinary calcium loss is widely discussed, but little evidence have supported a connection 
between these factors (Eisenstein, Roberts et al. 2002). The protein source is also of 
importance in a HP diet, due to variations in macro- and micronutrient composition (Gilbert, 
Bendsen et al. 2011). While dairy products are rich in calcium, oily fish is rich in ω-3 fatty 
acids and meats from terrestrial animals are rich in saturated fat. The mutual characteristics 
of animal proteins are that they contain all 9 essential amino acids necessary for protein 
turnover, and are thereby classified as complete proteins. 
 
The effect of protein on satiety 
 
The weight regulating effects of HP diets may be attributed to increased satiety and thereby 
a reduced energy intake (Blouet, Mariotti et al. 2006; Westerterp-Plantenga, Lemmens et al. 
2012). Various physiological mechanisms have been proposed to explain the satiating effect 
of proteins, including gastric hormones and circulating amino acids. Animal studies with rats 
have demonstrated that proteins are the most potent food stimulant for the release of the 
peptide hormone cholecystokinin (CCK) compared to fat and carbohydrates (Liddle, Green et 
al. 1986; Douglas, Woutersen et al. 1988). CCK is known for its appetite suppressing abilities 
through slowing down gastric emptying, which may lead to a reduced energy intake (Little, 
Horowitz et al. 2005). 
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In addition to gastric hormones, circulating amino acids in plasma might be recognized as a 
satiety signal. High circulating levels of the essential amino acid tryptophan has been linked 
to a higher satiety sensation in lean men, likely due to tryptophan’s role in the synthesis of 
the appetite modulating neurotransmitter serotonin (Uhe, Collier et al. 1992). The branch 
chained amino acid (BCAA) leucine has been known to stimulate mammalian target of 
rapamycin (mTOR) signalling via the hormone leptin and thereby increase the sense of 
satiety in the ventromedial nuclei in the hypothalamus (Cota, Proulx et al. 2006). Moreover, 
a rat study illustrated another positive connection between leucine and high levels of the 
adipose tissue-derived hormone leptin (Lynch, Gern et al. 2006). A 40 % reduction in leptin 
secretion was observed in rats receiving a leucine-deficient meal, whereas no differences 
were seen when other amino acids were eliminated. All combined, the satiating effects 
modulated by HP diets may explain a share of its effects on weight management and energy 
intake. 
 
The effect of protein on energy expenditure 
 
An alternative process by which the HP diets may exercise their weight-stabilizing effects is 
through diet-induced thermogenesis (DIT). The thermic effect of food is based on the energy 
required for digestion, absorption and disposal of ingested nutrients (Halton and Hu 2004). 
Ingestion of protein-rich foods has been known to promote a higher diet-induced 
thermogenesis (20-30%) compared to carbohydrates (5-10 %) and fat (0-3 %) (Tappy 1996). 
In contrast to most nutrients the body has no storage capacity for amino acids, which results 
in immediate metabolic processing through gluconeogenesis, ureagenesis and protein 
turnover (Giordano and Castellino 1997; Mikkelsen, Toubro et al. 2000). Thus, HP diets may 
affect energy expenditure by preserving muscle mass and maintaining protein turnover 
despite fluctuations in body weight. Furthermore, energy expenditure may be increased by 
an up-regulation of UCP1 in white adipose tissue. The amino acid tyrosine is a precursor to 
norepinephrine, which may stimulate UCP1 expression and increase energy expenditure via 
β-adrenoreceptor stimulation (Cannon and Nedergaard 2004). Conclusively, it is plausible 
that a HP diet increases energy expenditure more than diets rich in fat or carbohydrates.  
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The effect of protein on insulin metabolism 
 
The metabolic hormones insulin and glucagon may also influence the weight-regulating 
effect of HP diets. Insulin is known to exert an anabolic effect in healthy individuals by 
promoting fat and glucose storage, impeding fat oxidation and repressing gluconeogenesis 
(Woerle, Meyer et al. 2003; Cherrington 2005). The obesogenic effect of insulin is confirmed 
by reports showing that mice lacking insulin receptors in adipose tissue or have no 
expression of the pancreatic Ins2 gene is protected against diet-induced obesity (Bluher, 
Michael et al. 2002; Mehran, Templeman et al. 2012). HP diets have been known to improve 
insulin sensitivity compared to diets rich in carbohydrate, and increase plasma levels of 
glucagon (Madsen, Pedersen et al. 2008). While carbohydrates are the main stimulants for 
insulin secretion, various protein sources appear to have different insulinotropic properties. 
Ingestion of dairy proteins have been known to induce a greater insulin response than beef 
and fish proteins, possibly due to an increment in plasma amino acids mediated by the 
BCAAs (Gannon, Nuttall et al. 1988; Calbet and MacLean 2002). Furthermore, leucine has 
been identified as the sole amino acid to interact directly with the insulin pathway and 
maintain glucose homeostasis (Devkota and Layman 2010). On the contrary, other studies 
have shown a connection between high levels of BCAAs in fasting plasma and development 
of insulin resistance in mice fed a high-fat diet (Newgard 2012). Cod proteins contain high 
amounts of the organic acid taurine, a potent antioxidant. Administration of taurine has 
been linked to an improved insulin sensitivity in rats with insulin resistance and type 2 
diabetes by inhibiting pancreatic β-cell oxidation and increasing the secretion of cholesterol 
into bile acid (Nakaya, Minami et al. 2000; Nandhini, Thirunavukkarasu et al. 2005). The 
effect of different proteins on insulin metabolism is currently under debate, and no 
definitive answer has been presented. 
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1.4 INTRODUCTION TO THE STUDY  
New dietary trends emerge continuously, and recently high-protein diets have gained more 
attention as a method for weight-regulation. A review by Westerterp-Plantega confirmed 
the beneficial effects of high-protein diets on weight loss and energy expenditure, as well as 
its modulating effects on satiety sensation (Westerterp-Plantenga 2008). 
Several studies from our group and elsewhere have demonstrated that a high amount of 
dietary protein attenuates obesity development and reduces energy intake in mice (Madsen, 
Pedersen et al. 2008; Ma, Liaset et al. 2011; Lillefosse, Tastesen et al. 2013).  Additionally, 
high-protein diets have been associated with increased cAMP signaling, which allows 
metabolic processes associated with fasting to occur in a fed state (Madsen, Pedersen et al. 
2008). Furthermore, an up-regulation of Ucp1 in iWAT has been observed in mice given a 
high amount of dietary protein, which can possibly be related to the observed weight loss in 
humans maintaining a high-protein diet. 
The most frequently used protein in feeding trials with rodents is casein, while commonly 
used proteins in a human diet also include eggs, fish and various meats from terrestrial 
animals. Hence, the use of a sole protein source in nutritional studies has produced little 
evidence regarding the obesogenic effect of various protein sources. In the light of these 
facts, a previous study in our group was conducted to investigate whether a high proportion 
of other protein sources were able to protect against diet-induced obesity in the same 
degree as casein. Consequently, obesity prone C57BL/6J mice were fed high-fat high-protein 
diets with soy, casein, cod or proteins from terrestrial animals (pork, chicken and beef). In 
concurrence with previous studies, casein was the only protein source that attenuated 
obesity development. On the contrary, the mice fed high proportions of beef, cod, pork or 
chicken became heavier than mice fed a high-fat high-sucrose reference diet. Last year, a 
follow-up study was conducted to investigate the adipogenic effect of protein:sucrose ratio 
in combination with casein, cod and pork proteins. Hence, paired groups of C57BL/6J mice 
were fed high-fat high-sucrose and high-fat high-protein diets. An increased amount of 
dietary sucrose elevated the body weight significantly in mice fed casein or pork, compared 
to the diet with a high amount of protein. Mice receiving cod protein did however not have 
significant variations between the groups. As in the previous study, casein was the only 
protein source that attenuated diet-induced obesity in a high-fat high-protein diet. 
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1.5 AIM OF THE STUDY  
 
In view of the finding that of all protein sources tested, only a high proportion of dietary 
casein has been able to protect against diet-induced obesity, this study had one primary aim, 
and two secondary aims: 
 
 Primarily, this study aimed to investigate if the dietary protein source is of 
importance in relation to obesity development, satiety sensation, energy expenditure 
and glucose tolerance. 
 Secondly, we aimed to investigate if proteins from cod are more satiating then 
proteins from pork.  
 Lastly, we aimed to investigate the effect of different protein sources on weight loss 
and improvement of glucose tolerance. 
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2. MATERIALS AND METHODS 
 
2.1 THE ANIMAL EXPERIMENTS 
Male C57BL/6JBomTac mice were chosen for these experiments due to their ability to 
develop obesity, hyperinsulinemia and hyperglycemia when fed a high-fat diet (Black, Croom 
et al. 1998). Additionally, the C57BL/6J strain retains a low adipose tissue mass when fed a 
LF diet (Petro, Cotter et al. 2004).  
 
 
 
 
 
Figure 2.1: Private photo of a C57BL/6J mouse. 
Ethical statement 
All animal protocols used during the experiment were approved by the Norwegian Animal 
Health Authorities. 
ANIMAL EXPERIMENT 1: 
Fifty-four male C57BL/6J mice were obtained from Taconic Europe (Ejby, Denmark) at 8 
weeks of age. The mice were acclimatized for one week on a LF diet before the feeding 
experiment started. After one week of acclimatization, the mice were weighed and scanned. 
The mice were then divided into 6 groups (n=9), making sure that each group had a similar 
body weight, lean mass and fat mass. Tests were performed during the feeding experiment, 
including collection of feces, an oral glucose tolerance test (OGTT) and an insulin tolerance 
test (ITT). The mice were fed the experimental diets for 12 weeks prior to termination. 
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ANIMAL EXPERIMENT 2: 
Seventy male C57BL/6J mice were obtained from Taconic Europe (Ejby, Denmark) at 7 weeks 
of age. The mice were fed a very high-fat diet (VHF) for 13 weeks before the feeding 
experiment was initiated. The mice were then divided into 4 groups (n=13) that had a similar 
body weight, lean mass and fat mass. Feces were collected before and after the diet 
experiment as well as OGTTs and ITTs. The mice were fed the experimental diets for 6 weeks 
prior to termination. Animal experiment 2 was performed in collaboration with Nina 
Norberg. 
Housing and feeding 
The mice were housed in individual cages (Techniplast 1291) in a controlled environment 
throughout the experiments. Each cage was equipped with a house, nesting material, a 
chewing stick and wooden bedding (Scanbur Bedding Aspen, Norway). The animal room had 
a 12 hour light/dark cycle, and was thermoneutral (29.35 ± 2.3°C) with an average humidity 
of 37.9 %. The mice were fed three times a week, and their water was changed twice a week 
throughout the experiments.  
Measurements 
The mice were weighed every Monday morning on a Mettler Toledo weight. They were 
scanned with a Bruker Minispec LF50mq7.5 apparatus before each feeding experiment, 
halfway through the experiment, and again before termination. The scanner contains a 
magnetic field that differentiates lean mass, fat mass and free water. Feed and feed 
remnants were weighed each Monday, Wednesday and Friday. The wooden bedding was 
sifted biweekly, to collect and weigh spilled feed. 
Diets 
ANIMAL EXPERIMENT 1: 
The six groups were given five different diets, presented in figure 2.2. Two groups were 
given either a low fat (LF) or a high-fat high-sucrose (HF/HS) reference diet, and four groups 
were given experimental high-fat high-protein (HF/HP) diets with different protein sources. 
Two of the groups receiving HF/HP diets were pair fed throughout the experiment. 
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Figure 2.2: Grouping, diets and protein sources in animal experiment 1. 
Casein sodium salt from bovine milk was bought from SIGMA (lot number BCBF8389V). Pork 
sirloin was obtained from H. Brakstad Eftf. AS meat processing and cod fillet was a gift from 
Lerøy seafood. The cod fillet and pork sirloin were freeze dried and pulverized at NIFES, 
mixed with the other diet ingredients in a Crypto Peerless EF20 blender and kept in a freezer 
throughout the experiment. The distribution of macronutrients in the diets are presented in 
figure 2.3 as energy percent (E %). For a detailed overview of the diet compositions, see 
appendix I table A.1.  
L F
S u c ro s e P ro te inF a t S ta rc h
1 0 %
5 3 %
1 6 %
2 1 %
3 %
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4 6 %
1 %
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H F /H P
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3 3 %
 
Figure 2.3: Distribution of fat, sucrose, protein and starch in the LF reference diet, HF/HS 
reference diet and the HF/HP experimental diets (E %). 
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ANIMAL EXPERIMENT 2: 
After 13 weeks on a VHF diet, the four groups of mice were assigned to different diets. In the 
first week of experimental feeding, all groups were fed ad libitum. From week 2 group 1 
received a VHF diet as a reference, and groups 2-4 were given 30 % calorie restricted LF diets 
with casein, cod or pork as the protein source.  The protein sources and preparation of the 
LF diets were as described in experiment 1, while the VHF diet was obtained from Ssniff 
(Soest, Germany). The distribution of macronutrients in the LF diets were identical to the LF 
diet presented above in figure 2.3. For a detailed overview of the diet compositions, see 
appendix I table A.2. The distribution of macronutrients in the VHF diet is presented in figure 
2.4 as energy percent (E %) 
C a rb o h y d ra te s
P ro te in
F a t
5 6  %
1 8  %
2 6  %
V H F
 
Figure 2.4: Distribution of fat, protein and carbohydrates in the VHF diet (E %). 
 
Collection of feces 
A collection of feces was performed to calculate apparent fat digestibility. The mice were 
transferred to clean cages with a sheet of paper or wooden bedding in the bottom, and fed 
as previously described. After one week the feces were collected and technicians analyzed 
the fecal fat content. Later, the apparent fat digestibility (AFD) was calculated using the 
following formula: 
AFD= ((amount of fat eaten-amount of feces excreted)/amount of fat eaten) x 100% 
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Termination 
Prior to termination, the mice were weighed and put in smaller cages. All the mice were in a 
randomly fed state. 
The mice were anaesthetized with Isofluran (Isoba-vet, Schering Plough, Denmark) in a 
Univentor 400 Anesthesia Unit apparatus (Univentor Limited, Sweden). The sternum was cut 
open, and the mice were euthanized by cardiac puncture. Blood was collected with a syringe 
connected to a tube containing an EDTA anticoagulant. The blood samples were then 
centrifuged at 2500 x g for 5 minutes at 4 °C to separate the plasma from red blood cells and 
stored at - 80 °C foregoing analysis.  
Tissue and organ harvesting 
Three adipose tissue depots were excised during the termination: Visceral epididymal white 
adipose tissue (eWAT), inguinal subcutaneous white adipose tissue (iWAT) and intrascapular 
brown adipose tissue (iBAT). Additionally, the liver and pancreas were excised. The tissue 
and organ samples were weighed, and divided into bags/cassettes. Tissue samples for 
quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) analyses were freeze clamped 
and stored at -80 °C, and samples for histology were fixed in 4 % formaldehyde.  
2.2 ORAL GLUCOSE TOLERANCE TEST (OGTT) 
An OGTT test was performed to evaluate glucose tolerance. Before the test, the mice were 
moved to clean cages and fasted for six hours. They were then given an oral dose of (1 g/kg 
lean mass) glucose, distributed with a gavage needle. A small incision was made at their 
lateral tail vein to collect blood, and the blood glucose levels were measured in a fasted 
state and after 15, 30, 60 and 120 minutes with an automatic glucometer (Contour ®NEXT, 
Bayer). Blood samples (20 µl) were collected for further insulin analysis at T0, 15 and 30 min. 
The blood samples were centrifuged at 2500 x g for 5 minutes at 4 °C and the plasma was 
subsequently stored at -80 °C. The mice’s tails were sterilized with 70 % EtOH at the end of 
the test to prevent infection. Fasting blood glucose- and serum insulin levels from the OGTT 
were later used to calculate HOMA-IR with the following formula:  
(Fasting blood glucose (mmol/L) x fasting plasma insulin (mU/L)/22.5) 
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2.3 INSULIN TOLERANCE TEST (ITT) 
An ITT was performed to evaluate insulin response. The mice were moved to clean cages 
with no food available during the test and an intraperintonal injection of insulin (0.1 U/kg 
lean mass) was given to each mouse. An incision was made at their lateral tail vein and blood 
glucose levels were measured at T0, 15 min, 30 min, 45 min and 60 min. The mice’s tails 
were sterilized at the end of the test.  
2.4 ELISA INSULIN KIT 
The Mouse Insulin ELISA kit (DRG Instruments, GmbH, Germany) was used for quantitative 
determination of insulin in mouse plasma. Reagents are listed in appendix II, table A.3. 
The ELISA kit and samples were thawed, and 10 µl of the calibrators and serum samples 
were transferred into a 96 well microplate. Enzyme Conjugate 11x and Enzyme Conjugate 
Buffer was mixed, and 100 µl was added to each well. The plate was then incubated on a 
shaker for two hours, allowing the insulin in the samples to react with peroxidase- 
conjugated anti-insulin antibodies and anti-insulin antibodies bound to the wells. 
Furthermore, the plate was washed to remove unbound enzyme labeled antibodies. Two 
hundred µl substrate TMB was then added into each well, allowing the antibody-bound 
enzymes to convert the uncolored TMB into a colored product. The reaction was stopped by 
adding Stop Solution to each well. Conclusively, optical density was measured at 450 and 
620 nm with a spectrophotometric plate reader (iEMS Reader MF, Labsystems, Helsinki). A 
more detailed description can be obtained from the DRG® Insulin (Mouse) ultrasensitive 
ELISA protocol (DRG 2013) 
2.5 HISTOLOGY 
2.5.1 Fixation with paraformaldehyde and phosphate buffer (PB) 
Samples of adipose tissue (iWAT, eWAT and eBAT) were excised and placed in plastic 
cassettes. The tissue samples were then fixated in 4% paraformaldehyde in 0.1 M phosphate 
buffer (PB) overnight. The tissues were transferred to PB with a few drops of 
paraformaldehyde the next day, and stored for 4 days at 4 °C. Paraformaldehyde was added 
to the PB to prevent enzymatic and bacterial tissue degradation. 
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2.5.2 Dehydration with ethanol and xylene 
The PB was replaced with gradually increasing concentrations of ethanol, as presented 
below in table 2.1. When the tissues were completely dehydrated in 100% ethanol, the 
ethanol was replaced with xylene. Replacing ethanol with xylene is imperative, as xylene is 
soluble in both paraffin and alcohol.  
Table 2.1: Reagents and time span of each step in the dehydration process. 
      
 
 
 
 
 
2.5.3 Paraffin infiltration and embedding 
The casettes containing the tissues were stored in liquid paraffin (Histowax, Histolab 
products AB, Sweden) over night. The following day tissues were embedded in paraffin using 
an EC 350 Paraffin embedding center (Microtom International GmbH, Germany). Liquid 
paraffin was poured into a metal mold, and the tissue sample was placed in the center. 
Subsequently, the bed of the cassette was placed on top of the mold and filled with paraffin. 
The paraffin was then solidified in a freezer, and the solid block was finally removed from 
the mould. 
2.5.4 Sectioning and staining 
A microtome (Leica RM2156, Germany) was used to cut 3 µm sections of the embedded 
tissues. The sections were placed in dissected water and transferred to glass slides to dry 
overnight. In order to analyze the slides with a microscope, the sections were stained with a 
combination of dyes. The reagents and time span of each step is presented in table 2.2.  
 
Reagent  Time 
75 % EtOH  45 min 
95 % EtOH  2 x 45min 
100 % EtOH  3 x 45 min 
Xylene  2 x 45 min 
Paraffin  overnight 
Paraffin  2 x 15 min 
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Hematoxylin was used to stain the cell nucleus and eosin was used to stain the cytoplasm.  
After staining, the sections were mounted with a xylene based mounting medium 
(Microscopy, Entellan, Germany) and left to dry overnight. Chemicals and reagents used in 
the histological methods are listed in appendix III table A.4. 
Table 2.2: Reagents and time span of each step in the rehydration-staining-dehydration 
process. 
 
 
 
 
 
 
 
 
2.5.5 Microscopy 
The cell morphology of iWAT and iBAT from the different groups was examined by using an 
Olympus BX 51 binocular microscope. A representative field of the section was 
photographed with an Olympus DP50 3.0 camera.  
2.6 MEAL TOLERANCE TEST (MTT) 
A meal tolerance test (MTT) was performed on a third set of young normal-weight mice. The 
mice were transferred to individual cages and fasted for approximately 16 hours. In the 
following morning, the lateral tail vein was punctured and blood glucose concentrations 
were measured using a glycometer (Ascensia, COUNTOUR, USA). Furthermore, 20 µl fasting 
blood samples were collected from each mouse prior to the test. The mice were then given 
access to 0.15 grams of either the LF, HF/HP casein, HF/HP cod or HF/HP pork diets for 
approximately 15 minutes.  
Reagent   Time 
Xylene  2 x 10 min 
100 % EtOH  2 x 10 min 
95 % EtOH  2 x 5 min 
75 % EtOH  5 min 
50 % EtOH  5 min 
ddH2O  Wash 
Hematoxylin  2 min 
H2O   Wash 
Eosin  30 sec 
95 % EtOH  Wash 
ddH2O  1 min  
50 % EtOH  2 min 
75 % EtOH  2 min 
95 % EtOH  2 x 2 min 
100 % EtOH  2 x 5 min 
Xylene   2 x 5 min 
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Blood glucose concentrations were measured immediately after the food was removed and 
then again 15, 30, 60 and 120 minutes after food ingestion. Furthermore, 20 µl of blood was 
collected from each mouse at T15, T30 and T60. At completion of the MTT, the mice were 
placed back into their original cages. The collected blood was later used to measure plasma 
insulin levels by enzyme-linked immunosorbent assay (ELISA).   
2.7 AMINO ACID ANALYSES 
Laboratory technicians at NIFES performed analyses of amino acids. Amino acids in the diets 
were detected using a method of HCl hydrolysis, derivatization by AccQ.TagTM Ultra 
Derivatization Kit (Waters, Kjeller, Norway) and finally analysis by UPLC and UV-detection 
(Waters Aquity, Kjeller, Norway). Free amino acids in plasma were measured using ninhydrin 
detection on the Biochrom 30+ instrument (Cambridge, UK). 
2.8 STATISTICAL ANALYSES 
2.8.1 Microsoft excel 2013 
Microsoft excel was used to process raw data, and calculate the standard error of the mean 
(SEM). 
2.8.2 Graph Pad Prism 6 
Graph Pad Prism 6 was used to test the normality of the data by using a D’Agostino-Pearson 
normality test and outliers were identified with Grubb’s test. A one-way analysis of variance 
(ANOVA) with multiple comparisons was used to analyse differences between the 
experimental groups. The reference groups were excluded from the statistical analyses. P 
values <0.05 were considered as statistically significant. 
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3. RESULTS 
 
 
3.1 FEEDING EXPERIMENT 1 
Previous studies from our group have demonstrated that high-protein diets with casein as 
the protein source reduce feed efficiency and body weight gain (Madsen, Pedersen et al. 
2008; Ma, Liaset et al. 2011).  In order to evaluate the effect of different proteins on diet-
induced obesity, C57BL/6J mice were fed the experimental high-protein diets presented in 
table A.1 for 12 weeks.  
3.1.1 Body mass gain and obesity development 
The body mass development and total body weight gain after 12 weeks of experimental 
feeding is presented as means ± SEM in figure 3.1. 
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Figure 3.1: Body mass development (A) and weight gain (B) in groups (n=9) of C57BL/6J mice fed reference 
diets or HF/HP diets with casein, cod or pork as the protein source. A: Body mass development during the 12 
weeks of experimental feeding. To compare the weekly body mass development, the data were analyzed with 
ANOVA repeated measures of the mean of each experimental group. B: Body mass increase after 12 weeks of 
experimental feeding. To compare the total body weight gain in the experimental groups, the data were 
analyzed using a one-way ANOVA test with multiple comparisons of the mean of each group. Different letters 
denote statistical significance (p<0.05) between the mean of the groups. The results are presented as mean ± 
SEM. 
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As presented in figure 3.1 A, the different protein sources stimulated weight gain at different 
rates. After only 3 weeks of experimental feeding, the mice fed HF/HP casein had a 
significantly lower weight gain than the HF/HP pork group. Furthermore, ANOVA analysis at 
5 weeks showed a significantly lower weight gain in the HF/HP casein group compared to 
both HF/HP groups fed pork. After 6 weeks of feeding, the casein-fed mice had a significantly 
lower weight gain than all the other experimental groups. In summary, the group fed 
proteins from pork had the highest weight gain, while cod protein had an intermediate 
effect. Casein was the only protein source that exerted a weight-stabilizing effect, which 
concurs with previous unpublished results from our group.  
The total weight gain was of statistical significance in both pork fed groups and the group fed 
cod when compared to casein (figure 3.1 B). However, the differences in weight gain in the 
pair fed groups was not of statistical significance. In summary, the various protein sources 
had different effects on body weight development. 
MRI scans of fat and lean mass 
To determine if the weight gain was due to an increased amount of lean- or fat mass, the 
mice were MRI scanned prior to the feeding experiment and after 6 and 9 weeks of feeding. 
The results from the MRI scan in week 9 are presented in figure 3.2 as means ± SEM. 
When casein was used as a protein source, the lean mass (fat-free body mass) was 
significantly higher than in both groups fed pork (Fig 3.2 A). However, there were no 
significant differences between the group fed cod protein and the other groups. As 
illustrated in figure 3.2 B, the group receiving casein as the protein source had significantly 
less fat mass than the groups fed pork or cod protein. A significant difference was also seen 
between the cod and both pork fed groups, with the pork groups having the highest fat 
mass. The data illustrates that protein source affect both lean and fat mass development, 
though the weight gain must be attributed to the increased fat mass. 
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Figure 3.2: Lean mass (A) and fat mass (B) after 9 weeks on the experimental diets. A and B: Differences in 
lean- and fat mass were analyzed using a one-way ANOVA test with multiple comparisons of the mean of each 
experimental group. Different letters denote statistical significance (p<0.05) between the mean of the groups. 
The results are presented as mean ± SEM. 
 
Adipose tissue depots 
Three fat mass depots were examined by excising and weighing the adipose tissue depots 
during termination. Visceral (eWAT) and subcutaneous (iWAT) white adipose tissue was 
collected, in addition to brown adipose tissue (iBAT).  
As presented in figure 3.3 A, the group fed casein had a significantly lower eWAT mass then 
both pork-fed groups and the group fed cod. The group fed cod protein had a lower eWAT 
mass than the groups fed pork, though it was not of statistical significance. The iWAT masses 
of casein-fed mice were also significantly lower than in the group fed cod, as well as both 
groups fed pork (Fig 3.3 B). Furthermore, a significant difference was seen between the 
group fed cod and the two pork-fed groups. When casein was used as a protein source, the 
iBAT weight was significantly lower than in the pork group (Fig 3.3 c). The iBAT masses of the 
groups fed cod or pork PF were not of statistical significance when compared to the other 
groups. In conclusion, the dietary proteins affected fat-deposition differently. 
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Figure 3.3: Masses of eWAT (A), iWAT (B) and iBAT (C) after 12 weeks on the experimental diets. A, B and C: 
Group variations in eWAT, iWAT and iBAT mass were analyzed using a one-way ANOVA test with multiple 
comparisons of the mean of each experimental group. Different letters denote statistical significance (p<0.05) 
between the mean of the groups. The results are presented as mean ± SEM. 
 
Adipocyte size 
The adipocyte size in one white (iWAT) and brown (iBAT) fat depot was examined by staining 
and photographing a representative part of a section.   
The photographs illustrate that the casein-fed mice had the smallest white adipocytes 
compared to the hypertrophic cells seen in cod, and especially in pork. While the iBAT in the 
casein group mainly consists of multilocular adipocytes, the iBAT from the pork group solely 
consists of unilocular “white” adipocytes. Thus, the different protein sources also affected 
adipose tissue development at a cellular level. 
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                                       iWAT HF/HP Casein                                   iBAT HF/HP Casein  
 
       
 
 
                                                          iWAT HF/HP Cod                                          iBAT HF/HP Cod       
 
 
 
 
                                                          iWAT HF/HP Pork                                          iBAT HF/HP Pork       
 
Figure 3.4: Adipocyte morphometry in subcutaneous adipose tissue (iWAT) and intrascapular brown adipose 
tissue (iBAT) in mice fed casein, cod or pork as the protein source (magnified 40x). 
Liver mass 
To assess the effect of different proteins on other organ masses, the livers were excised 
during termination. 
As presented in figure 3.5 the mice fed casein had a significantly lower liver mass compared 
to the cod-fed group. However, no significant differences were found in the two groups fed 
pork. Although the experimental diets affected liver mass differently, the variations do not 
constitute a major difference in total body weight gain.  
The pancreas was also excised and weighed during termination, but the differences between 
groups were not statistically significant. The figure of pancreas masses is presented in 
appendix IV table A.5. 
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Figure 3.5: Liver masses in the different groups. Differences in liver mass were analyzed using a one-way 
ANOVA test with multiple comparisons of the mean of each experimental group. Different letters denote 
statistical significance (p<0.05) between the mean of the groups. The results are presented as mean ± SEM. 
3.1.2 Glucose tolerance and insulin sensitivity 
Oral glucose tolerance test (OGTT) 
To evaluate the impact of dietary protein source on glucose tolerance, fasting mice were 
subjected to an oral glucose test (OGTT) after 10 weeks of experimental feeding. The results 
from the OGTT are presented in figure 3.6 as means ± SEM.  
According to the OGTT data, glucose tolerance appears to be related to body weight in most 
groups (Fig 3.6). Before glucose administration, there were no significant differences 
between the experimental groups (Fig 3.6 C). All the groups peaked 15 minutes after glucose 
ingestion, but neither the measurements at 15 minutes (Fig 3.6 D) nor the calculated delta 
insulin (Fig 3.6 E) showed significant variations. A significant variation was observed after 60 
minutes, where the casein group had a significantly lower blood glucose concentration than 
both pork groups. After 120 minutes all the groups had an equal or lower blood glucose 
concentration compared to their starting values. In summary, the pork groups had the most 
elevated glucose levels during the OGTT, while the casein group had the lowest. The mice in 
the cod group had intermediate blood glucose concentrations. 
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Figure 3.6: Oral glucose tolerance test (OGTT) on fasting mice (6 h) performed after 10 weeks on the 
experimental diets. A: Blood glucose levels during the OGTT. Blood glucose levels from T30-T120 were analyzed 
with ANOVA repeated measures with multiple comparisons of the mean of each experimental group. B: 
Calculated area under curve. C: Fasting blood glucose. D: Blood glucose after 15 minutes E: Delta blood glucose. 
F: Fasting plasma insulin. G: Glucose stimulated insulin secretion after 15 minutes. H: Delta insulin. B-H: 
Differences in blood glucose -and insulin levels were analyzed using a one-way ANOVA test with multiple 
comparisons of the mean of each experimental group. Different letters denote statistical significance (p<0.05) 
between the mean of the groups. The results are presented as mean ± SEM. 
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A one-way ANOVA analysis of the glucose AUC showed that the group fed casein had a 
significantly better glucose clearance compared to the pork group (Fig 3.6 B). The pork PF 
group and the group fed cod also had an elevated AUC compared to casein, but neither were 
significant.  
The insulin secretion during the OGTT was measured in fasting mice, after 15 minutes and 
the delta insulin was calculated (Fig 3.6 F-H). Fasting insulin levels were significantly elevated 
in the pork PF group compared to the casein-fed group, while the cod group had an 
intermediate insulin level (Fig 3.6 F). Furthermore, figure 3.6 G illustrates that the glucose 
stimulated insulin secretion (GSIS) after 15 minutes was elevated in the cod group and pork 
PF group, but none of the variations between the groups were significant. The delta insulin 
levels revealed that the group fed pork had secreted most insulin from 0-15 minutes, but no 
significant results were obtained (Fig 3.6 H). 
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Insulin tolerance test (ITT) 
An insulin tolerance test was performed after 11 weeks of experimental feeding to explore 
the connection between different proteins and the development of insulin-resistance. The 
results from the ITT are presented in figure 3.7 as means ± SEM. 
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Figure 3.7: Insulin tolerance test (ITT) performed after 11 weeks of feeding. A: Blood glucose levels during the 
ITT. Blood glucose levels from T0-T60 were analyzed with ANOVA repeated measures with multiple 
comparisons of the mean of each experimental group B: Calculated area under curve (mmol/L x 60 min). C: 
Calculated decremental AUC ((T0*60) - AUC). B and C: The AUC and decremental AUC were analyzed using a 
one-way ANOVA test with multiple comparisons of the mean of each experimental group. Different letters 
denote statistical significance (p<0.05) between the mean of the groups. The results are presented as mean ± 
SEM. 
The results from the insulin tolerance test (ITT) showed an association between a high body 
weight and a lowered insulin sensitivity (Fig 3.7). There were no significant differences in 
blood glucose levels at the start of the test, but the group fed casein had significantly lower 
blood glucose levels then the other experimental groups at 15 and 30 minutes after insulin 
injection. Further ANOVA analyses at 45 and 60 minutes showed that the casein-fed group 
had significantly lower blood glucose levels then both groups fed pork. 
The calculated AUC revealed that the casein group had a significantly better glucose uptake 
in response to insulin compared to the other groups (Fig 3.7 B). There were no significant 
variations between the other groups, although the groups fed pork had a slightly higher AUC 
then the cod-fed group.  
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By calculating decremental AUC (DAUC) and thereby eliminating the differences in fasting 
glucose levels, the group variations became more prominent (Fig 3.7 B). The mice fed casein 
had a significantly higher drop in blood glucose in response to the insulin than the pork 
group, while the cod- and pork PF groups had no significant variations.  
HOMA-IR 
To further evaluate insulin sensitivity, a homeostasis model assessment – insulin resistance 
(HOMA-IR) index was calculated. A high HOMA-IR score is correlated with insulin resistance 
or type 2 diabetes. The calculated HOMA-IR scores are presented in figure 3.8 as mean ± 
SEM. 
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Figure 3.8:  Calculated HOMA-IR scores. The HOMA-IR scores were analyzed using a one-way ANOVA test with 
multiple comparisons of the mean of each group. Different letters denote statistical significance (p<0.05) 
between the mean of the groups. The results are presented as mean ± SEM.   
As presented in figure 3.8 the mice fed casein had a significantly lower HOMA-IR score 
compared to the pork PF group. The cod-fed group had a lower HOMA-IR score compared 
with the pork PF group, but it did not reach statistical significance. These findings indicate 
that the protein types exert different insulinotropic effects.  
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Meal tolerance test 
A meal tolerance test (MTT) was performed on young mice with a normal weight to further 
investigate what effects the experimental diets exert on insulin secretion. The blood glucose 
levels and calculated AUCs are presented in figure 3.9 as means ± SEM. 
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Figure 3.9:  Meal tolerance test (MTT). A: Blood glucose curve from the MTT. B: Blood glucose AUC. C: Insulin 
curve from the MTT. D: Insulin AUC. The results are presented as mean ± SEM.   
As presented in figure 3.9, the MTT did not provide any significant results when the 
experimental groups were compared.  
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3.1.3 Energy intake and feed efficiency 
To investigate if the differences in body weight was due to a varied feed intake, the total 
calorie intake was calculated. Additionally, feed efficiency was calculated to determine the 
obesogenic effect of the different proteins. 
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Figure 3.10: Energy intake after 12 weeks of feeding (A) and feed efficiency (B). B: Differences in feed efficiency 
were analyzed using a one-way ANOVA test with multiple comparisons of the mean of each experimental 
group. Different letters denote statistical significance (p<0.05) between the mean of the groups. The results are 
presented as mean ± SEM. 
 
Differences in feed intake were not significant, though the group fed casein had a slightly 
higher calorie intake than the other groups (Fig 3.10 A). The two pair-fed groups, cod and 
pork PF, had a variation of 15 kcal in energy intake after 12 weeks of feeding. In contrast to 
the energy intake, the group fed casein had significantly lower feed efficiency compared to 
the other groups (Fig 3.10 B).  Furthermore, the cod group had a significantly lower feed 
efficiency then the pork group. However, there were no significant differences between the 
pair-fed groups. 
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Apparent fat digestibility 
To evaluate if the observed weight gain was caused by less fat excretion, feces were 
collected and their fat content was analyzed.  
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Figure 3.11: Apparent fat digestibility. Differences in apparent fat digestibility were analyzed using a one-way 
ANOVA test with multiple comparisons of the mean of each experimental group. Different letters denote 
statistical significance (p<0.05) between the mean of the groups. The results are presented as mean ± SEM. 
Interestingly, we observed that the casein fed group had digested significantly more fat then 
the group fed cod (Fig 3.11). The pork-fed groups had an intermediate fat digestibility, but 
was not statistically different compared to the other groups.  
 
3.1.4 Plasma analyses 
Free amino acids in plasma 
To uncover group variations in the free amino acid pool, non-fasting mouse plasma samples 
were sent for analysis. Both amount and types of free amino acids may be of importance in 
the development of obesity, due to their different effects on satiety and energy expenditure.   
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Figure 3.12: Free amino acids and in non-fasting mouse plasma (µmolAA/100 ml plasma) in the HF/HP casein, 
cod and pork fed groups.  
 
As presented in figure 3.12 the total amount of free amino acids (AAs) was highest in the 
group fed casein, including the branched-chained amino acids (BCAAs). The cod and pork 
groups had a quite similar content of free AAs, but lower values of the BCAAs and several 
non-essential AAs compared to casein. For a more detailed overview, the AA values in 
plasma are listed in appendix V table A.6. Additional analyses of AAs in the experimental 
diets and protein sources are presented in appendix V figure A.7 and A.8, respectively. 
Urea and taurine levels in plasma 
As presented in figure 3.13 A, the group fed casein had a significantly higher amount of urea 
in plasma compared to the group fed cod and the pork group. When cod was used as a 
control group, ANOVA analysis showed a significantly higher level of taurine in the plasma of 
cod-fed mice compared to the other groups (Fig 3.13 B). 
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Figure 3.13: Plasma levels of urea (A) and taurine (B) in non-fasting mouse plasma (µmolAA/100 ml plasma).A: 
Differences in plasma levels of urea were analyzed using a one-way ANOVA test with multiple comparisons of 
the mean of each experimental group. Different letters denote statistical significance (p<0.05) between the 
mean of the groups. B: Differences in plasma levels of taurine in the experimental groups were analyzed using 
a one-way ANOVA test with the cod as the control group. Different letters denote statistical significance 
(p<0.05) compared to the cod group. The results are presented as mean ± SEM.  
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3.2 FEEDING EXPERIMENT 2 
To evaluate the effect of different proteins on weight reduction, diet induced obese (DIO) 
C57BL/6J mice were given calorie restricted (30%) low fat diets with casein, cod or pork as 
the protein source. Results from this experiment are also presented in Nina Norberg’s 
master thesis. 
3.2.1 Body mass development and weight reduction  
The body mass development and body mass reduction after 5 weeks of experimental 
feeding is presented in figure 3.14 as means ± SEM. 
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Figure 3.14: Body mass development (A) and body weight reduction (B) in groups (n=13) of C57BL/6J mice fed 
LF diets with casein, cod or pork as the protein source for 5 weeks. B: Differences in body weight reduction 
were analyzed using a one-way ANOVA test with multiple comparisons of the mean of each experimental 
group. Different letters denote statistical significance (p<0.05) between the mean of the groups. The results are 
presented as mean ± SEM. 
As presented in figure 3.14 A, the proteins exerted various effects on body mass 
development. After five weeks of experimental feeding, the casein-fed group had lost 
significantly more body mass then the other experimental groups (Fig 3.14 B). 
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MRI scans of fat and lean mass 
To determine if the weight loss was due to a decreased amount of lean- or fat mass, the 
mice were MRI scanned prior to the diet intervention and after 5 weeks of experimental 
feeding. The differences in lean-and fat mass from week 0-5 are presented in figure 3.15 as 
means ± SEM. 
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Figure 3.15: Changes in lean- (A) and fat mass (B) from week 0-5.A and B: Differences in lean-and fat mass were 
analyzed using a one-way ANOVA test with multiple comparisons of the mean of each experimental group. 
Different letters denote statistical significance (p<0.05) between the mean of the groups. The results are 
presented as mean ± SEM. 
As illustrated in figure 3.15 A, the cod-fed mice had a significant increase in lean mass 
compared to casein after 5 weeks of experimental feeding. The casein-fed group had the 
greatest reduction in fat mass after 5 weeks of experimental feeding, but differences 
between the groups did not reach statistical significance (Fig 3.15 B). 
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3.2.2 Glucose tolerance and insulin sensitivity 
 
Oral glucose tolerance test (OGTT) 
To evaluate if the different proteins improved glucose tolerance, fasting mice were 
subjected to an oral glucose test (OGTT) after 5 weeks of experimental feeding. The results 
from the OGTT are presented in figure 3.16 as means ± SEM. 
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Figure 3.16: Oral glucose tolerance performed on fasting mice (6 h) after 5 weeks of experimental feeding. A: 
Blood glucose levels during the OGTT. B: Calculated area under curve. C: Fasting blood glucose. D: Blood 
glucose after 15 minutes E: Delta blood glucose. Differences in blood glucose levels and AUC were analyzed 
using a one-way ANOVA test with multiple comparisons of the mean of each experimental group. Different 
letters denote statistical significance (p<0.05) between the mean of the groups. The results are presented as 
mean ± SEM. 
According to the OGTT results, the amount of weight loss appears to correlate with an 
improved glucose tolerance (Fig 3.16). Fasting blood glucose levels were significantly lower 
in the group fed casein compared to the other LF groups (Fig 3.16 C), and measurements 
after 15 minutes were significantly lower in the casein-fed mice compared to the group fed 
pork (Fig 3.16 D).  
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The delta blood glucose revealed no significant variations (Fig 3.16 E), while the calculated 
AUC was significantly lower in the casein group compared to the other experimental groups 
(Fig 3.16 B). Notably, all experimental groups had an improved glucose tolerance after 5 
weeks of experimental feeding. 
Insulin tolerance test (ITT) 
To evaluate if the different protein sources improved insulin sensitivity, the mice were 
subjected to an insulin tolerance test after 4 weeks of experimental feeding. The results 
from the ITT are presented in figure 3.17 as means ± SEM. 
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Figure 3.17: Insulin tolerance test (ITT) performed after 4 weeks of experimental feeding. A: Blood glucose 
levels during the ITT. B: Calculated AUC. Differences in AUC were analyzed using a one-way ANOVA test with 
multiple comparisons of the mean of each group. Different letters denote statistical significance (p<0.05) 
between the mean of the groups. The results are presented as mean ± SEM. 
As presented in figure 3.17, the amount of weight loss correlated with an improved insulin 
sensitivity. The calculated AUC was significantly lower in the casein-fed mice compared to 
the other LF groups. In summary, all the experimental groups had become more insulin-
sensitive after 4 weeks of feeding. 
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4. DISCUSSION 
 
Numerous animal studies have demonstrated that a high proportion of dietary casein 
abrogates the obesogenic effect of fat (Madsen, Pedersen et al. 2008; Ma, Liaset et al. 2011; 
Lillefosse, Tastesen et al. 2013). An unpublished study from our group, which aimed to 
investigate if a high amount of other protein sources could induce the same weight- 
regulating effect as casein in a HF/HP diet, discovered that neither of the other proteins 
tested were able to protect against diet-induced obesity. In fact, proteins from pork 
promoted obesity development while proteins from cod had an intermediate effect. 
Unpublished studies from our group have also registered a lower feed intake in mice fed cod 
protein compared to mice fed pork, which raises a question whether cod promotes satiety in 
a higher degree than pork. Based on these observations we found it interesting to 
investigate if the higher satiating effect of cod protein affected energy intake, and then 
eliminate the eventual satiating variations by pair-feeding mice fed cod and mice fed pork. 
Furthermore, we found it compelling to explore the weight-reducing effects of the same 
protein sources on diet induced obese (DIO) mice. Our present studies demonstrate that the 
dietary protein source is an important factor in both high-and regular-protein diets.  
4.1 A HIGH PROPORTION OF DIETARY CASEIN ATTENUATES THE OBESOGENIC 
EFFECT OF A HIGH-FAT DIET 
High protein diets have been presented as a beneficiary method for maintaining a stable 
body weight and attenuate obesity development, but the focus on different dietary protein 
sources have been scarce. Here we report how various dietary proteins exert different 
effects on body mass and metabolism in mice fed a HF/HP diet. In concurrence with earlier 
publications from our group, we found that casein was the only protein source that 
attenuated obesity development in a HF/HP diet. Furthermore, the mice that were fed diets 
with pork as the protein source developed obesity and gained a significant amount of fat 
mass, while cod protein exercised an intermediate obesogenic effect. Hence, we 
demonstrate that the source of dietary protein is of great importance.  
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4.1.1 The effect of different protein sources on satiety 
High-protein diets have been known to induce a greater appetite suppressing effect than 
diets high in fat or carbohydrates, but there is little evidence regarding the satiating effects 
of specific proteins. In the present study we investigated if the increased weight gain 
observed in mice fed pork was due to a lowered satiety and thereby increased energy intake, 
by pair-feeding the group fed cod and one of the groups fed pork. A former study has 
demonstrated that fish proteins have a higher satiating effect than beef and chicken, while 
our group previously observed a higher energy intake in mice fed pork compared to mice fed 
cod (Uhe, Collier et al. 1992). In contrast to these observations we found that the pair-fed 
pork group needed almost no energy restriction to match the energy intake in the group fed 
cod. Additionally, we observed that the ad libitum fed pork group only consumed 30 kcal 
more than the group fed cod during the 12 weeks of feeding. These findings are in 
agreement with studies showing that the satiating effects of different proteins may be 
superseded in high protein diets, due to the high satiating power of a large protein intake 
(Bowen, Noakes et al. 2006; Bowen, Noakes et al. 2006). Thus, our results imply that the 
obesogenic effect of pork protein in this study cannot be attributed to a lower satiating 
effect.  
Another interesting observation in our study was that the mice fed casein had the highest 
energy intake of all the experimental groups, despite having the lowest body weight. By 
analyzing non-fasting plasma samples we observed that cod- and pork-fed mice had a similar 
amount of free AAs in plasma, whilst the casein fed mice had higher amounts of circulating 
AAs, including the BCAAs. Circulating levels of AAs, especially the BCAA leucine, has been 
described as a potent satiety stimulator via its regulatory effects on leptin secretion and 
hypothalamic mTOR signaling (Cota, Proulx et al. 2006). However, these mechanisms did not 
seem to reduce the energy intake in our casein-fed mice. A plausible explanation for the 
variations in energy intake observed in our group may be the inconsistent use of protein 
sources and the different textures of the experimental diets. While we used minced cod fillet 
in the present study, previous studies have used cod fish powder. These are factors that 
influence taste and texture, and quite possibly the energy intake. 
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 4.1.2 The effect of different protein sources on energy expenditure 
Although we observed no significant differences in energy intake between the experimental 
groups, the differences in feed efficiency were very pronounced. Interestingly, we 
discovered that the mice fed casein had a significantly lower feed efficiency than the other 
groups as well as the highest energy intake. Additionally, we observed a significantly lower 
energy efficiency in the group fed cod compared to the pork-fed group. These differences in 
in feed efficiency may be related to the impact of different proteins on energy expenditure 
through various metabolic processes.  
Casein differs from the other protein sources with its high content of the BCAA leucine, 
which is known to exert an anabolic effect on skeletal muscle and thereby increase protein 
turnover (Norton, Layman et al. 2009). The significantly higher amount of lean mass in our 
casein-fed mice imply that they have an elevated protein turnover compared to the other 
experimental groups, which can be related to their higher energy intake. Furthermore, by 
analyzing non-fasting plasma samples we detected significantly higher levels of urea in 
plasma from mice fed casein, which might suggest that they have a more effective nitrogen 
excretion. An elevated ureagenesis can be advantageous as it leads to an increased amount 
of carbon skeletons available for de novo synthesis of glucose via gluconeogenesis, which in 
turn promotes glucose homeostasis. In addition to the BCAAs and urea, we found the 
highest level of tyrosine in the plasma of casein-fed mice. Tyrosine is known as a precursor 
to norepinephrine, which may enhance energy expenditure through β-adrenergic 
stimulation and expression of the Ucp1 gene in WAT (Cannon and Nedergaard 2004). 
Unfortunately we did not get to measure mRNA levels of Ucp1  in our study due to 
unforeseen complications, but earlier studies from our group have detected increased 
expression of Ucp1 in iWAT of mice fed HF/HP diets (Madsen, Pedersen et al. 2008; Ma, 
Liaset et al. 2011). 
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The difference in energy efficiency between cod -and pork-fed groups cannot be explained 
by the BCAA or urea content, but we speculate if the higher levels of arginine found in 
plasma of mice fed cod could partly account for their lower body weight. In support of this 
argument, two studies have demonstrated that dietary supplementation of arginine 
successfully reduced body weight and fat mass in rats (Fu, Haynes et al. 2005; Jobgen, 
Meininger et al. 2009).  Additionally, a recent study showed that 4 weeks of fish protein 
supplementation increased lean mass and reduced fat mass in human subjects (Vikoren, 
Nygard et al. 2013). Nevertheless, the effect of specific proteins and AAs on energy 
expenditure is a field that requires more research, and we can merely speculate if their 
properties can exert any significant effects.  
Another factor that may influence energy expenditure is the possibility of obesity-induced 
whitening in BAT by adipocyte transdifferentiation or de novo synthesis of precursor cells. 
Sectioning and staining of BAT revealed that the casein-fed mice had a normal BAT 
morphology mostly consisting of multilocular adipocytes, while the BAT in the pork group 
had the same appearance as WAT. The BAT from mice fed cod had an intermediate 
morphology between that of BAT and WAT, mostly consisting of unilocular adipocytes. We 
found these variations surprising, considering that our animal experiment was carried out in 
thermoneutral surroundings. Studies have shown that a positive energy balance causes an 
expansion of the existing WAT which promotes either a direct transformation of heat-
producing brown adipocytes into white adipocytes (Cinti, Frederich et al. 1997) or synthesis 
of white adipocytes from precursor cells (Bachman, Dhillon et al. 2002). However, the 
literature is mainly focused on induced browning in WAT, while little emphasis is put on the 
mechanisms leading to the whitening of BAT in mice exempt from thermal stress. One study 
addressed this topic and demonstrated that Ucp1 ablation solely induced obesity 
development and abolished DIT in mice housed in a thermoneutral environment (Feldmann, 
Golozoubova et al. 2009). The underlying mechanisms of BAT-whitening may be partly 
elucidated by the lowered sympathetic activity observed in obese men and mice, but this 
topic is clearly in need of further exploration. In conclusion, we cannot be certain if the 
whitening of BAT had any negative influence on energy expenditure in the current study, but 
we observed a pattern between increased adiposity and the degree of whitening in BAT.  
 
 50 
 
4.1.3 The effect of different protein sources on fat absorption 
An additional factor that may account for some of the differences in feed efficiency is the 
percentage of digested and excreted fat. Our calculations of apparent fat digestibility (AFD) 
showed that the group fed cod had digested a significantly lower amount of fat than the 
group fed casein. The lowered fat digestibility in cod was not significantly different 
compared to the pork PF group, but an increased fat excretion may partly account for their 
differences in body weight. It has been hypothesized that the different AA compositions of 
the protein sources may influence fat absorption, but the literature presents meager 
evidence. A study by Murakami and colleagues proposed that a long-term supplementation 
of taurine increased bile secretion and thereby fat absorption in C57BL/6J mice (Murakami, 
Kondo et al. 2000), while human studies have observed a decreased fatty acid excretion in 
children with cystic fibrosis given taurine supplements (Smith, Lacaille et al. 1991). These 
findings are clearly contradicting to our observations, where the cod-fed mice had the 
lowest fat absorption in addition to the highest levels of taurine. In conclusion, the lower 
AFD in mice fed cod may partly explain the differences in energy efficiency observed 
between them and the groups fed pork, whereas the higher AFD in mice fed casein appears 
to be contradicting.  
4.1.4 The effect of different protein sources on glucose tolerance and insulin sensitivity 
Glucose intolerance, insulin resistance and obesity is so closely related that researchers in 
the 1970s invented the term “diabesity” (Sims, Danforth et al. 1973). In concurrence with 
this term, we observed that an impaired glucose tolerance and reduced insulin sensitivity 
was directly related to increased adiposity. The results from the OGTT demonstrated that 
the mice fed casein had a significantly lower AUC than the pork group, as well as a 
significantly lower blood glucose 60 minutes after glucose administration. Additionally, 
fasting insulin levels were significantly lower in the group fed casein compared to the pork 
PF group. This implies that the mice fed pork have an impaired glucose tolerance, and that 
the lower blood glucose levels observed in casein-fed mice is not due to an increased insulin-
secretion. In the present study, we based the glucose dosage on lean mass weight instead of 
BW, given that lean mass is the main target for glucose uptake. This method is believed to 
provide more robust results, especially when there are great group variations in lean mass.  
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High blood glucose levels are often related to high insulin levels. To explore if this 
connection was relatable to our study, an ITT where the mice were given 1.0 U/kg lean mass 
was performed. In direct relation to the OGTT, we found that the casein-fed group had a 
significantly lower AUC than the other groups. Furthermore, calculation of DAUC illustrated 
that the mice fed casein had a significantly better glucose uptake in response to insulin than 
the pork PF group, while the cod-fed group and pork PF group had intermediate responses. 
The results from the OGTT and ITT could then be translated into a HOMA-IR index, which 
was significantly higher in the pork PF group compared to the group fed casein.  
To further evaluate the insulinotropic properties of the different protein sources, we 
performed an MTT on young normal-weight mice who had been fasted overnight. 
Unfortunately, the MTT did not produce any significant results. A study by Andrikopoulos 
and colleagues evaluated the glucose tolerance test in mice, and demonstrated that a low 
glucose dosage (0.5-1 g/kg) generated an insufficient response in blood glucose levels 
(Andrikopoulos, Blair et al. 2008). We therefore speculate if the amount of food given at the 
test (0.15 g) was too low to produce an adequate response. 
In addition to the effects of excess fat mass, certain AAs have been known to exert various 
insulinotropic effects. We contemplate if the higher levels of the BCAAs in non-fasting 
plasma may be related to the insulin-sensitive properties observed in the mice fed casein. 
Both human and rat studies have demonstrated that leucine and isoleucine improve blood 
glucose clearance and uptake in skeletal muscle in acute-response studies (Doi, Yamaoka et 
al. 2007; Kalogeropoulou, Lafave et al. 2008). While others argue that leucine and the BCAAs 
actually promote insulin resistance and hyperinsulinemia, this theory is based on fasting 
levels of BCAAs in plasma. In relation to our study, we only observed that higher levels of 
BCAAs in non-fasting plasma improved glucose tolerance. In relation to the differences in 
glucose tolerance we observed in the mice fed cod and pork, we contemplate if the organic 
acid taurine may exert any regulatory effects. There is a possible connection between the 
significantly higher levels of taurine in the plasma of mice fed cod and an improved insulin-
sensitivity. Previous rat studies have demonstrated a positive correlation between taurine 
and an improvement of diabetes (Nakaya, Minami et al. 2000; Nandhini, Thirunavukkarasu 
et al. 2005).  
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Collectively, the data indicate that the mice fed casein have a normal response to insulin and 
glucose, while the mice fed pork have an impaired glucose tolerance. Furthermore, these 
results are consistent with body mass development and the morphological differences we 
observed in the adipose tissue.  
4.2 CASEIN PROMOTES WEIGHT LOSS IN OBESE MICE FED A LOW FAT DIET 
LF diets have been a popular dietary method for reducing calorie intake, and thereby reduce 
body weight. Several studies have reported positive effects on weight loss and glucose 
tolerance when diet-induced obese (DIO) mice are switched from a HF to a calorie restricted 
LF diet, but the role of dietary protein source has not been sufficiently explored (Parekh, 
Petro et al. 1998; Shi, Akunuru et al. 2009). Here we report how various proteins exert 
different effects on weight loss and glucose tolerance in DIO mice.  
We found that proteins from casein produced a significantly greater body mass reduction 
compared to pork and cod proteins, and it was the most efficient protein source in terms of 
fat-mass reduction. However, a 30% calorie restriction was necessary to promote an 
adequate weight loss. When the mice were fed LF diets ad libitum in the first week of the 
trial, we observed a marginal weight reduction and differences between the groups were 
undefined. This observation can be related to the more gluttonous behavior observed in 
animals fed diets with a moderate protein content, which emphasizes the necessity of 
calorie restriction in the present study (Stock 1999).  
Interestingly, we observed that mice fed the LF cod diet had a significantly higher increase in 
lean mass (fat-free body mass) then the casein-fed mice after 5 weeks of experimental 
feeding. An increase in lean mass after fish protein supplementation was also observed in a 
human study with overweight candidates ; however, calorie restriction was not enforced 
(Vikoren, Nygard et al. 2013). Another interesting discovery was that all the groups fed LF 
diets gained more lean mass compared to the VHF reference group, despite having a much 
lower dietary energy- and protein content.  
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Amelioration of glucose tolerance and insulin sensitivity 
The DIO mice were subjected to an OGTT and ITT before and after the diet intervention to 
examine the dietary effect on glucose tolerance and insulin sensitivity. We found that the 
DIO mice had a lowered glucose tolerance before the intervention, in addition to insulin-
resistance. Remarkably, these parameters were radically altered after 4 weeks of 
experimental feeding. The casein fed mice had a significantly lower glucose and insulin AUC 
compared to the other groups, which could be mediated by the hypothesized insulin-
sensitizing effect of the BCAAs. In support of this finding, a study by Kawaguchi and 
colleagues demonstrated that daily supplementation of BCAAs improved insulin resistance in 
men with chronic liver disease (Kawaguchi, Nagao et al. 2008). Compared to our previous 
HF/HP study the mice fed LF casein also had the best glucose tolerance, despite being fed a 
lower amount of dietary protein. Surprisingly, the group fed cod had the highest AUC in both 
the ITT and OGTT tests in the current study, suggesting that a lower amount of cod protein 
might not produce the same effects as the high amount in the HP diet. In conclusion, the 
positive effects of casein might be less dose-dependent than the effects of cod protein.  
4.3 THE ANIMAL MODEL AND RELAVANCE TO HUMANS 
Mice are the most commonly used animal models in nutritional research, due to their 
genetic and physiological similarities to humans. However, it is essential to consider that 
mice used for research purposes mostly are inbred strains with less genetic variance than 
humans. Hence, it is not reasonable to interpret effects in a specific strain as general, as it 
may be a unique feature for the actual strain. The C57BL/6J mice model used in these 
feeding experiments is characterized by its ability to develop DIO, hyperinsulinemia and 
hyperglycemia when fed a HF diet. Thus, this specific strain provides an excellent model to 
study the pathophysiology of an obesity syndrome quite similar to human obesity. 
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The Norwegian health authorities give specific advice on the most beneficial types of fat and 
carbohydrates to consume, but their focus on protein sources has been limited. In the 
present study we have demonstrated that the choice of dietary protein source also is an 
important factor in the development of obesity. The obesogenic effect of pork protein is 
thought provoking, as it constitutes a large component of a typical Western diet. 
Fortunately, the Norwegian health authorities “degraded” pork from white to red meat in 
2013, which may imply that more specific advice on protein sources is emerging.  While 
whole-fat dairy products have been branded as a source of unhealthy saturated and trans-
fatty acids for humans, we only observed positive effects of a HF/HP casein diet in our 
primary trial. Additionally, we observed the positive effects of casein in the LF-trial, 
indicating that low-fat dairy products also are beneficiary. However, we may not state 
anything as definite when we compare the monotonous mouse diets with a normal and 
varied food intake. Conclusively, it remains to be seen if our results have human relevance.  
4.4 FUTURE PERSPECTIVES 
The present study demonstrated that casein attenuates obesity development in a HF/HP 
diet. In future studies, it would be interesting to investigate the effects of different types of 
fish and seafood in HP diets. Since cod protein produced intermediate results in our current 
study, it would be exciting to see if other marine proteins could exert different effects. 
To further elucidate the underlying mechanisms of thermogenesis and energy expenditure in 
HP diets, we could have performed a qRT-PCR analysis of Ucp1 levels in BAT. Additionally, 
we could have measured protein levels of UCP1 in BAT and WAT with immunohistochemical 
staining or a western blot. These analyses would be especially interesting to perform on the 
varied morphologies we observed in BAT. Additionally, it would be interesting to study the 
effect of β-adrenergic stimuli on UCP1 expression. 
Furthermore, it would be interesting to explore the effects of gut bacteria on nutrient 
absorption and excretion in diets with different macronutrient compositions. Other 
interesting analyses would be to measure and compare AA levels of mice or humans in a fed 
and fasted state. 
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Our second feeding experiment was conducted to investigate the weight reducing effects of 
different proteins on DIO mice fed a LF diet. In future studies it would be interesting to 
observe if HP and Western diets with different protein sources could promote weight loss in 
DIO mice.  
Lastly, it would be of great importance to explore if the effects we observed in mice could be 
mimicked in humans. To gain a deeper understanding of the therapeutic effects of proteins 
in human nutrition, it is necessary to conduct more human intervention trials with different 
proteins sources and elucidate the effects on energy expenditure and other parameters.  
  
5. CONCLUSION 
 
The current study presents one main finding, and two secondary findings:  
 
 Primarily, we report that a high amount of dietary casein attenuates obesity 
development in C57BL/6J mice fed a high-fat high-protein diet. The beneficial effects 
of the high-protein diet with casein as the protein source appears to involve several 
metabolic mechanisms, including increased energy expenditure and a decreased 
dietary-induced insulin secretion.  
 Secondly, we report that there were no differences in the satiating effects of cod and 
pork proteins. 
 Lastly, we report that a low fat diet with casein as the protein source produces the 
greatest weight-loss in obese mice. 
 
Allthough the results obtained from the animal experiments cannot be directly linked to 
human nutrition, our findings suggests that it may be beneficial to partially replace pork with 
casein and moderate amounts of cod. Further research on this field is paramount in order to 
elucidate the underlying mechanisms of obesity and explore their potential role in human 
nutrition.  
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APPENDIX 
Appendix I – Diets 
Table A.1: Diet compositions and analyzed nutrients in animal experiment 1 (g/kg). 
 
Fat from the casein powder contributed with 1.14 g/kg in the LF and HF/HS groups and 2.27 g/kg in the HF/HP 
Casein group. Fat from the cod fillet and pork sirloin contributed with 2.64 and 22.38 g/kg fat, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
Group     1 2 3 4 5 
(g/kg)     Low fat High fat 
        Sucrose Protein Protein Protein  
Ingredients  Casein Casein Casein Cod Pork 
Casein   206 206 413 - - 
Cod  - - - 400 - 
Pork  - - - - 438 
L-Cystine  3 3 3 3 3 
Sucrose  100 440 210 210 210 
Corn oil  69 249 248 247 205 
Cellulose  50 50 50 50 50 
t-Butylhydroquinone  0.014 0.014 0.014 0.014 0.014 
Min.mix: SDS, AIN93Gminmix 35 35 35 35 35 
Vit.mix: SDS, AIN93VX 
NCR95compliant 10 10 10 10 10 
Choline Bitartrate  2.5 2.5 2.5 2.5 2.5 
Potato starch (Dextrin)   524 4 29 42 46 
Sum   1000 1000 1000 1000 1000 
Analyzed 
Crude fat   71 250 250 240 250 
Crude protein  200 190 380 400 390 
Cholesterol  0.043 0.024 0.111 1.013 0.741 
Energy (kJ/g)   18.2 22.9 24.0 23.6 24.2 
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Table A.2: Diet compositions and analyzed nutrients  in animal experiment 2 (g/kg). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fat from the casein, cod and pork proteins contributed with 1.14, 1.32 and 22.38 g/kg fat, respectively. 
 
Appendix II – ELISA insulin kit 
Table A.3: Reagents in the Insulin Mouse Ultrasensitive Elisa Kit. 
    
Product  Vender 
Insulin Mouse Ultrasensitive ELISA Kit  DRG Instruments GmbH, Germany 
Coated plate  
Calibrator 0 (1 vial)  
Calibrator 1,2,3,4 and 5 (5 vials)  
Enzyme Conjugate 11X (1 vial)  
Enzyme Conjugate buffer (1 vial)  
Wash buffer (1 bottle)  
Substrate TMB (1 bottle)  
Stop solution (1 vial)  
  
  
Group                                                                                             1                      2                     3 
(g/kg)   Low fat 
Ingredients   Casein Cod Pork 
Casein   206 - - 
Cod   - 200 - 
Pork   - - 218 
L-Cystine   3 3 3 
Sucrose   91.8 91.8 91.8 
Corn oil   68.8 68.6 47.6 
Cellulose   50 50 50 
t-Butylhydroquinone  0.01 0.01 0.01 
Min.mix: SDS, AIN93Gminmix 35 35 35 
Vit.mix: SDS, AIN93VX 
NCR95compliant 10 10 10 
Choline Bitartrate  2.5 2.5 2.5 
Dextrin from Melis  1.84 1.84 1.84 
Potato starch (Dextrin)   532 538 541 
Sum 1000.00 1000.00 1000.00 
Analyzed 
Crude fat 71 74 72 
Crude protein 190 200 200 
Energy (kJ/g) 18.2 18.1 18.2 
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Appendix III – Histological methods 
Table A.4: Chemicals and reagents used for fixation, dehydration, embedding, sectioning and 
staining.  
    
Product  Vender 
4 % formaldehyde Merck, Germany 
NaH2PO4 x H2O Merck, Germany 
Na2HPO4 x H2O Merck, Germany 
Ethanol  Arcus, Norway  
Rectified Alcohol Arcus, Norway  
Xylene Prolabo 
Paraffin Histovax, OneMed 
Hematoxylin EMS 
Eosin Y Sigma, USA 
Mounting medium Merck, Germany 
    
 
 
Appendix IV – Pancreas mass 
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Figure A.5: Pancreas masses in the different groups. The results are presented as means ± SEM. 
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Appendix V – Amino acid analyses 
Table A.6: Free amino acids in non-fasting mouse plasma (µmol aa/ 100 ml plasma). 
Free amino acids in plasma 
µmol aa/ 100 ml plasma  LF HF/HS Casein Cod Pork PF Pork 
Histidine 8.4 7.9 7 6.6 7.4 7.3 
Isoleucine 10.9 9.8 11.9 11 10.5 9.6 
Leucine 18.5 16.9 20 17.3 16.7 15.7 
Lysine 47.5 46 38.1 32.4 33 29.1 
Methionine 11.7 10.8 10.5 8 7.3 6.2 
Phenylalanine 7.4 7.4 7.4 6.7 6.5 6.3 
Threonine 38 31.8 35.1 20.6 23.3 20 
Tryptophan 10.2 10.1 9.1 7.9 7.6 7.4 
Valine 30.8 28.1 34.7 27.2 25.4 23.3 
Alanine 81.9 73.4 63.7 48 52.1 46.4 
Arginine 7.1 7.6 6.6 8.4 8 6.9 
Aspargine 11.8 12.7 11.9 8.4 7.5 6.6 
Aspartic acid 2 1.9 1.8 1.7 1.6 1.5 
Cystein 2.6 2.7 2.9 2.6 3.1 3 
Glutamic acid 6 6.1 5.4 6.3 5.2 5 
Glutamine 59.4 61.7 54.2 56.2 55.7 56.5 
Glycine 29.9 26 31.6 26.3 24.8 24 
Hydroxyproline 2.2 1.6 1.4 1.4 1.8 1.6 
Proline 20.3 19.2 22.8 8.3 8.7 8.0 
Serine 22.6 19.7 18.8 12.5 12.6 11.9 
Tyrosine 11.8 12.7 12.2 8.7 7.9 7.5 
Sum essential AAs 183.3 168.8 173.8 137.8 137.7 124.9 
Sum non-essential AAs 175.7 245.3 233.2 189 188.9 178.6 
Sum BCAAs 37.8 34.6 38.9 34.9 34.6 32.6 
Total 359 414.1 407 326.8 326.6 303.6 
Taurine * 49.8 49.6 50.6 59.8 50 49.2 
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              Amino acid composition of the experimental diets (mg/g) 
 
Figure A.7: Amino acid composition of the experimental diets (mg/g). 
Figure A.8: Amino acid composition of the protein sources (mg/g). 
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